Harvest Group Wealth Management’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-84
Closed -$4K 510
2020
Q1
$4K Hold
84
﹤0.01% 269
2019
Q4
$5K Hold
84
﹤0.01% 352
2019
Q3
$4K Buy
+84
New +$3.95K ﹤0.01% 451

Other funds holding BMY

Harvest Group Wealth Management's BMY Position: Q2 2020 in Review

Harvest Group Wealth Management sold out of Bristol-Myers Squibb (BMY) in Q2 2020, closing a stake of 84 shares — an estimated $4K sold.

Harvest Group Wealth Management first reported a position in BMY in Q3 2019 and held it in 3 quarters. The position peaked at $5K in Q4 2019. 2,189 funds tracked by Wall St. Rank hold BMY as of Q2 2020.

  • Harvest Group Wealth Management reported no remaining Bristol-Myers Squibb position as of Q2 2020 after selling out during the quarter.
  • Harvest Group Wealth Management sold 84 Bristol-Myers Squibb shares in Q2 2020, an estimated $4K.
  • Harvest Group Wealth Management first reported a position in Bristol-Myers Squibb in Q3 2019 and held it in 3 quarters.
  • Harvest Group Wealth Management's Bristol-Myers Squibb position peaked at $5K in Q4 2019.
  • 2,189 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2020.

Based on Harvest Group Wealth Management's 13F filing for Q2 2020, filed 31 Jul 2020.